Stocks and Investing Stocks and Investing
Wed, March 9, 2022
Tue, March 8, 2022

Asthika Goonewardene Initiated (ACET) at Strong Buy and Held Target at $30 on, Mar 8th, 2022


Published on 2024-10-27 20:00:28 - WOPRAI, Asthika Goonewardene
  Print publication without navigation


Asthika Goonewardene of Truist Securities, Initiated "Adicet Bio, Inc." (ACET) at Strong Buy and Held Target at $30 on, Mar 8th, 2022.

Asthika has made no other calls on ACET in the last 4 months.



There are 2 other peers that have a rating on ACET. Out of the 2 peers that are also analyzing ACET, 0 agree with Asthika's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Asthika


  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Friday, March 4th, 2022
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $32 on, Monday, December 6th, 2021
Contributing Sources